Methods and systems for presenting a combination treatment

Patent metadata

Field	Value
Publication number	US-9026369-B2
Application number	US-29045608-A
Country	US
Kind code	B2
Filing date	Oct 29, 2008
Priority date	Apr 24, 2008
Publication date	May 5, 2015
Grant date	May 5, 2015

Abstract

Methods, computer program products, and systems are described that include accepting an indication of an individual's compliance with an artificial sensory experience and presenting an indication of a bioactive agent at least partly based on the indication of the individual's compliance with the artificial sensory experience.

First claim

What is claimed is:

1. A system comprising:
circuitry configured to accept an indication of usage by an individual of an artificial sensory experience; and
circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience.

2. The system of claim 1 , wherein the circuitry configured to accept an indication of usage by an individual of an artificial sensory experience comprises:
circuitry configured to accept an indication of usage by an individual of a prescribed artificial sensory experience.

3. The system of claim 1 , wherein the circuitry configured to accept an indication of usage by an individual of an artificial sensory experience comprises:
circuitry configured to accept a self-report of usage by an individual of an artificial sensory experience.

4. The system of claim 1 , wherein the circuitry configured to accept an indication of usage by an individual of an artificial sensory experience comprises:
circuitry configured to accept an indication from a health care provider of usage by an individual of an artificial sensory experience.

5. The system of claim 1 , wherein the circuitry configured to accept an indication of usage by an individual of an artificial sensory experience comprises:
circuitry configured to accept a report from an artificial sensory experience provider of usage by an individual of an artificial sensory experience.

6. The system of claim 1 , wherein the circuitry configured to accept an indication of usage by an individual of an artificial sensory experience comprises:
circuitry configured to accept an indication of usage by an individual of a virtual world.

7. The system of claim 1 , wherein the circuitry configured to accept an indication of usage by an individual of an artificial sensory experience comprises:
circuitry configured to accept an indication of interaction by an individual with an artificial sensory experience.

8. The system of claim 1 , wherein the circuitry configured to accept an indication of usage by an individual of an artificial sensory experience comprises:
circuitry configured to accept an indication of presence by an individual with respect to an artificial sensory experience.

9. The system of claim 1 , further comprising:
circuitry configured to accept a physiological measurement.

10. The system of claim 1 , further comprising:
circuitry configured to monitor a parameter.

11. The system of claim 1 , wherein the circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience comprises:
circuitry configured to present an indication of a prescription bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience.

12. The system of claim 1 , wherein the circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience comprises:
circuitry configured to present in near real-time an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience.

13. The system of claim 1 , wherein the circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience comprises:
circuitry configured to present an indication of a bioactive agent and a side effect at least partly based on the indication of usage by the individual of the artificial sensory experience.

14. The system of claim 1 , wherein the circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience comprises:
circuitry configured to present an indication of a bioactive agent at least partly based on an algorithm.

15. The system of claim 1 , wherein the circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience module comprises:
circuitry configured to present an indication of a bioactive agent at least partly based on a comparison.

16. The system of claim 1 , wherein the circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience comprises:
circuitry configured to present an indication of a bioactive agent at least partly based on a matching algorithm.

17. The system of claim 1 , further comprising:
circuitry configured for determining the bioactive agent.

18. The system of claim 1 , further comprising:
an output device.

19. The system of claim 1 , further comprising:
a user interface.

20. The system of claim 1 , further comprising:
a mobile device.

21. The system of claim 1 , wherein the circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience comprises:
circuitry configured to present to a third party an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience.

22. The system of claim 1 , wherein the circuitry configured to present an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience comprises:
circuitry configured to present to a health care provider an indication of a bioactive agent at least partly based on the indication of usage by the individual of the artificial sensory experience.

23. The system of claim 1 , further comprising:
circuitry configured to compare a physiological parameter value detected during usage by the individual of the artificial sensory experience with an expected physiological parameter value.

24. The system of claim 23 , further comprising:
circuitry configured to determine the bioactive agent based at least partly on the physiological parameter value detected during usage by the individual of the artificial sensory experience being other than the expected physiological parameter value.

25. The system of claim 24 , wherein the circuitry configured to determine the bioactive agent based at least partly on the physiological parameter value detected during usage by the individual of the artificial sensory experience being other than the expected physiological parameter value comprises:
circuitry configured to determine the bioactive agent (i) based at least partly on the physiological parameter value detected during usage by the individual of the artificial sensory experience being other than the expected physiological parameter value and (ii) based at least partly on a genetic profile of the individual.

26. The system of claim 1 , further comprising:
circuitry configured to monitor computer usage history associated with an individual with respect to a social networking application;
circuitry configured to determine that the individual is prone to depression based at least partly on the computer usage history associated with the individual with respect to the social networking app

Assignees

• Hyde Roderick A
• Ishikawa Muriel Y
• Leuthardt Eric C
• Levien Royce A
• Lord Robert W
• Malamud Mark A
• Sweeney Elizabeth A
• Wood Jr Lowell L
• Wood Victoria Y H
• Invention Science Fund I Llc

Inventors

• Hyde Roderick A
• Ishikawa Muriel Y
• Leuthardt Eric C
• Levien Royce A
• Lord Robert W
• Malamud Mark A
• Sweeney Elizabeth A
• Wood Jr Lowell L
• Wood Victoria Y H

Classifications

• G16H50/20

  for computer-aided diagnosis, e.g. based on medical expert systems · CPC title

• G16H20/10 Primary

  relating to drugs or medications, e.g. for ensuring correct administration to patients · CPC title

• G06F19/345

  Physics · mapped topic

• G06Q50/24

  Physics · mapped topic

• G06F19/3456

  Physics · mapped topic